Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
about
DACH1 inhibits transforming growth factor-beta signaling through binding Smad4The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complexNegative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5.Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1-regulated transcription factor ZONAB/DbpAUse of chromatin immunoprecipitation to clone novel E2F target promotersArrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcriptionThe N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrestE2F mediates induction of the Sp1-controlled promoter of the human DNA polymerase epsilon B-subunit gene POLE2The transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypesA comprehensive pathway map of epidermal growth factor receptor signalingRepression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylasesCyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivationA cell cycle regulatory network controlling NF-kappaB subunit activity and functionIntestinal tumor progression is associated with altered function of KLF5The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathwayGut-enriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motifMolecular interaction map of the mammalian cell cycle control and DNA repair systems.Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells.Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway.Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation.Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity.Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation.Target gene specificity of E2F and pocket protein family members in living cells.Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function.Ras-dependent cell cycle commitment during G2 phase.An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.Krüppel-like factor 5 mediates the transforming activity of oncogenic H-RasNew roles of cyclin D1.STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression.p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1.Transcriptional regulation of the cyclin D1 gene at a glance.The elements of human cyclin D1 promoter and regulation involved.ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information.
P2860
Q24296908-1B412132-B608-4E74-99CA-EB46610942E2Q24337174-8570C974-77C1-4B62-961B-667F965E84F9Q24534882-D59F050C-5519-40D1-85A0-C80EB51E4B90Q24535621-E3EC069B-ABF2-4E4D-A3E7-8CE7126E7F40Q24535932-6887C8A1-1D10-43D1-9467-AF6F736A189DQ24537644-7BE2136E-2EEA-4AA2-9A89-44ADEAE131E7Q24548016-5228E7CD-9C50-48D7-BBE7-FEEB91CCCA01Q24548317-2D3EC53E-B300-4D54-B64F-AFD431378858Q24554293-25EF265A-1635-4243-9D44-29138C2327B0Q24554327-B9899479-0941-43F5-BD0D-0CDC891B0574Q24555639-F9DA6A7F-3AC9-40A0-B2A6-E55EBAD51C3FQ24617123-39A46C39-7E89-4EAB-966A-6B231D81D205Q24672490-6417A45A-5007-459F-9CB8-FAF681030017Q24680884-4BB414F3-E8F6-4DA4-BBAF-7CC1289BCD79Q24684054-15C732CA-8707-445C-93A9-BEA6E489D5BAQ28116296-C30D31AF-046D-45B0-9F35-29E97DC8EB80Q28579165-183A78D0-F2AF-4ED0-A473-35D19A526174Q29615176-E874EA5D-1DEB-48F3-B4DD-3AF770ABC8BEQ33617171-3F2A3A6A-34D7-439B-8CEB-AB65FE4E242EQ33704559-99BDD754-E906-4732-8788-32A3C0CE1527Q33822845-F9B6C323-FE2C-41FC-A67D-6C8CD7E79907Q33854194-743F9F28-0596-4B68-B8D1-4199A458E90AQ33872322-37175B33-8D86-44FF-9580-448D443D93EAQ33880827-55AF3A48-BB7C-475B-BFF7-A23F984A4FABQ33884776-51FA7D98-464A-4763-BD6D-D5EEE5398E78Q33899255-141C8C4A-8D72-4265-B324-F9F732C54442Q33940612-676E90A7-84BC-4847-AB82-5095C2965BE0Q33964373-9ABE8E74-562C-497D-B824-253B2BFEA032Q33964977-976EC6E1-60DF-4E59-8E00-C73090C6451CQ33967999-8AC74EE0-8DB8-4B6B-8B64-59541D8EF804Q34125103-8FB11D0A-35A5-42EC-993E-DC5F15DA3382Q34164600-87DD3B0A-0C4C-4EC8-8453-784B6002E495Q34180275-A0B4EFDC-8EDC-4E3E-9229-4027233D82FEQ34312909-21AD2A21-D1D3-4536-BF06-F76A90A0F231Q34352513-57DB2589-CCE9-44FA-975C-7A8CA6417BBBQ34985773-E01ACDE2-BBA4-49AB-8DC7-50157FF0825FQ35150453-C1A39536-0971-453F-AE25-2DC0DA5E0286Q35985157-C4F02629-A5D0-42F2-B811-BAFAC8C21A33Q36002446-1BCDA26D-C791-455D-AF50-1424B56D0FAEQ36011094-A6D1DF45-DC46-4C08-8835-919AE755DB97
P2860
Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Inhibition of cyclin D1 kinase ...... activity through E2F and Sp1.
@ast
Inhibition of cyclin D1 kinase ...... activity through E2F and Sp1.
@en
type
label
Inhibition of cyclin D1 kinase ...... activity through E2F and Sp1.
@ast
Inhibition of cyclin D1 kinase ...... activity through E2F and Sp1.
@en
prefLabel
Inhibition of cyclin D1 kinase ...... activity through E2F and Sp1.
@ast
Inhibition of cyclin D1 kinase ...... activity through E2F and Sp1.
@en
P2093
P2860
P356
P1476
Inhibition of cyclin D1 kinase ...... activity through E2F and Sp1.
@en
P2093
B Henglein
C Albanese
G Watanabe
R G Pestell
P2860
P304
P356
10.1128/MCB.18.6.3212
P407
P577
1998-06-01T00:00:00Z